You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

Drugs

The drug library provides access to information on over 100 cancer drugs available for use in Canada.

Find more safety information in the supplementary patient handout How to Safely Take Your Oral Anti-Cancer Medication.

Displaying Drugs List

28 Items
Other Name(s): Casodex® (multiple brands available)
Funding:
ODB - General Benefit
  • bicalutamide
Sep 2019
Other Name(s): Suprefact® (Sanofi-Aventis); Suprefact Depot® (Sanofi-Aventis); Suprefact Nasal Spray® (Sanofi-Aventis)
Funding:
ODB - General Benefit
  • buserelin
Aug 2015
Other Name(s): Busulfex®; Myleran®
Funding:
ODB - General Benefit
  • busulfan - oral tablets
Jun 2019
Other Name(s): Xeloda®
Funding:
ODB - General Benefit
  • capecitabine
Dec 2019
Other Name(s): Leukeran®
Funding:
ODB - General Benefit
  • chlorambucil
Jun 2019
Other Name(s): Procytox®
Funding:
ODB - General Benefit
  • cyclophosphamide - oral tablets
Jun 2019
Other Name(s): Firmagon® ()
Funding:
ODB - General Benefit
  • degarelix
Aug 2018
Other Name(s): Vepesid®
Funding:
ODB - General Benefit
  • etoposide - oral capsules
Sep 2019
Other Name(s): Neupogen®; Grastofil®
Funding:
ODB - General Benefit
  • filgrastim - Grastofil brand is a general benefit
ODB Limited Use
  • filgrastim - (Neupogen brand) - Pre-Stem Cell Transplant Mobilization: For peripheral blood progenitor cell collection for peripheral stem cell transplant as treatment for malignant disease. Approval for Neupogen 300 mcg and 480 mcg vial format only.
  • filgrastim - (Neupogen brand) For pediatric patients (less than 18 years age) who are unable to achieve the appropriate dose of granulocyte colony-stimulating factor with the formulary listed formats of pre-filled syringes. Approval for Neupogen 300 mcg vial format only.
  • filgrastim - (Neupogen brand) For patients who are unable to use available formats of Grastofil due to a documented latex allergy. Approval for Neupogen 300 mcg and 480 mcg vial format only.
Sep 2019
Other Name(s): Euflex® (multiple brands available)
Funding:
ODB - General Benefit
  • flutamide
Aug 2014
Other Name(s): Zoladex® (AstraZeneca); Zoladex® LA (AstraZeneca)
Funding:
ODB - General Benefit
  • goserelin
Mar 2016
Other Name(s): Hydrea®
Funding:
ODB - General Benefit
  • hydroxyurea
Jun 2019